Edjah K. Nduom

2.5k total citations · 1 hit paper
45 papers, 1.7k citations indexed

About

Edjah K. Nduom is a scholar working on Genetics, Oncology and Immunology. According to data from OpenAlex, Edjah K. Nduom has authored 45 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 14 papers in Oncology and 10 papers in Immunology. Recurrent topics in Edjah K. Nduom's work include Glioma Diagnosis and Treatment (21 papers), Cancer Immunotherapy and Biomarkers (11 papers) and MicroRNA in disease regulation (7 papers). Edjah K. Nduom is often cited by papers focused on Glioma Diagnosis and Treatment (21 papers), Cancer Immunotherapy and Biomarkers (11 papers) and MicroRNA in disease regulation (7 papers). Edjah K. Nduom collaborates with scholars based in United States, China and Czechia. Edjah K. Nduom's co-authors include Amy B. Heimberger, Michael Weller, Konrad Gabrusiewicz, Jun Wei, Ling-Yuan Kong, Gregory N. Fuller, George A. Călin, Shouhao Zhou, Neal Huang and Xiaoyang Ling and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Nature Cell Biology.

In The Last Decade

Edjah K. Nduom

43 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PD-L1 expression and prognostic impact in glioblastoma

2015 457 citations Edjah K. Nduom, Jun Wei et al. Neuro-Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edjah K. Nduom United States	17	760	691	589	496	355	45	1.7k
Yuanxuan Xia United States	12	515 0.7×	402 0.6×	492 0.8×	436 0.9×	221 0.6×	43	1.4k
Yingmei Li China	20	428 0.6×	404 0.6×	438 0.7×	816 1.6×	407 1.1×	69	1.8k
Jana Portnow United States	18	713 0.9×	1.2k 1.7×	432 0.7×	800 1.6×	157 0.4×	60	2.2k
Patrick Healy United States	24	374 0.5×	970 1.4×	491 0.8×	592 1.2×	392 1.1×	98	2.0k
Matthew M. Grabowski United States	14	683 0.9×	276 0.4×	378 0.6×	177 0.4×	113 0.3×	36	1.1k
Priya Kumthekar United States	24	949 1.2×	854 1.2×	145 0.2×	414 0.8×	261 0.7×	146	2.1k
Fatima Khan United States	18	214 0.3×	566 0.8×	491 0.8×	772 1.6×	269 0.8×	38	1.6k
Rikke Hedegaard Dahlrot Denmark	18	544 0.7×	266 0.4×	215 0.4×	443 0.9×	319 0.9×	60	1.1k
Quintino Giorgio D’Alessandris Italy	27	651 0.9×	339 0.5×	105 0.2×	845 1.7×	557 1.6×	124	2.1k
Satoru Osuka Japan	21	390 0.5×	355 0.5×	166 0.3×	677 1.4×	314 0.9×	42	1.3k

Countries citing papers authored by Edjah K. Nduom

Since Specialization

Citations

This map shows the geographic impact of Edjah K. Nduom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edjah K. Nduom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edjah K. Nduom more than expected).

Fields of papers citing papers by Edjah K. Nduom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edjah K. Nduom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edjah K. Nduom. The network helps show where Edjah K. Nduom may publish in the future.

Co-authorship network of co-authors of Edjah K. Nduom

This figure shows the co-authorship network connecting the top 25 collaborators of Edjah K. Nduom. A scholar is included among the top collaborators of Edjah K. Nduom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edjah K. Nduom. Edjah K. Nduom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Hsiao‐Lin V., Tarun N. Bhatia, Yangping Li, et al.. (2025). Mapping the developmental trajectory of human astrocytes reveals divergence in glioblastoma. Nature Cell Biology. 27(2). 347–359. 2 indexed citations

Nduom, Edjah K., et al.. (2025). Macrophages in Glioblastoma and How Non-Coding RNAs Impact Their Differentiation. Cells. 14(19). 1528–1528. 1 indexed citations

Jahangiri, Arman, Fadi Jacob, Ali Alawieh, et al.. (2025). Patient-Derived Meningioma Organoids: A Reliable Model for Studying Human Tumor Pathophysiology. Cancers. 17(3). 526–526. 1 indexed citations

Bray, David P., et al.. (2024). Frailty in patients with IDH-mutant gliomas: experience from a high-volume tumor center. Journal of Neuro-Oncology. 168(3). 435–443. 2 indexed citations

Nduom, Edjah K., et al.. (2023). Extent of Resection and Outcomes of Patients with Primary Malignant Brain Tumors. Current Treatment Options in Oncology. 24(12). 1948–1961. 3 indexed citations

Barthélemy, Ernest J., Sylviane A. Diouf, Nancy Abu-Bonsrah, et al.. (2023). Historical determinants of neurosurgical inequities in Africa and the African diaspora: A review and analysis of coloniality. SHILAP Revista de lepidopterología. 3(2). e0001550–e0001550. 7 indexed citations

Nduom, Edjah K., John Glod, Desmond Brown, et al.. (2023). Clinical protocol: Feasibility of evaluating abemaciclib neuropharmacokinetics of diffuse midline glioma using intratumoral microdialysis. PLoS ONE. 18(9). e0291068–e0291068. 5 indexed citations

Bray, David P., Pia R. Mendoza, Gustavo Pradilla, et al.. (2022). Clinical and radiographic characteristics of diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma: a single institution review. Journal of Neuro-Oncology. 157(1). 187–195. 13 indexed citations

Eaton, Bree R., Elizabeth K. Butker, Jim Zhong, et al.. (2021). Phase I Dose Escalation Trial of Hypofractionated Radiosurgery for Large Intact or Resected Brain Metastases. International Journal of Radiation Oncology*Biology*Physics. 111(3). S25–S25. 2 indexed citations

10.

Medina, Rogelio, Herui Wang, Veronika Caisová, et al.. (2020). Induction of Immune Response against Metastatic Tumors via Vaccination of Mannan‐BAM, TLR Ligands, and Anti‐CD40 Antibody (MBTA). Advanced Therapeutics. 3(9). 16 indexed citations

11.

Acquaye, Alvina, Victoria Sánchez, Elizabeth Vera, et al.. (2020). Variations in attitudes towards stereotactic biopsy of adult diffuse midline glioma patients: a survey of members of the AANS/CNS Tumor Section. Journal of Neuro-Oncology. 149(1). 161–170. 3 indexed citations

12.

Jackson, Sadhana, Jon Weingart, Edjah K. Nduom, et al.. (2018). The effect of an adenosine A2A agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma. Fluids and Barriers of the CNS. 15(1). 2–2. 52 indexed citations

13.

Sánchez, Victoria, et al.. (2018). Current Options and Future Directions in Immune Therapy for Glioblastoma. Frontiers in Oncology. 8. 578–578. 24 indexed citations

14.

Linzey, Joseph R., Walavan Sivakumar, Jeremiah N. Johnson, et al.. (2018). Young Neurosurgeons Committee of the American Association of Neurological Surgeons: Training Ground for Future Leaders in Organized Neurosurgery in the United States of America. World Neurosurgery. 123. 59–63. 7 indexed citations

15.

Sánchez, Victoria, et al.. (2018). TMOD-05. GLIOMA-261 LUCIFERASE-EXPRESSING CELL LINE STIMULATES AN IMMUNOGENIC RESPONSE SIGNATURE IN AN IMMUNOCOMPETENT MURINE MODEL. Neuro-Oncology. 20(suppl_6). vi269–vi269. 1 indexed citations

16.

Pratt, Drew, Gifty Dominah, Victoria Sánchez, et al.. (2018). Programmed Death Ligand 1 Is a Negative Prognostic Marker in Recurrent Isocitrate Dehydrogenase-Wildtype Glioblastoma. Neurosurgery. 85(2). 280–289. 25 indexed citations

17.

Yaghi, Nasser K., Jun Wei, Yuuri Hashimoto, et al.. (2016). Immune modulatory nanoparticle therapeutics for intracerebral glioma. Neuro-Oncology. 19(3). now198–now198. 33 indexed citations

18.

Nduom, Edjah K., Michael Weller, & Amy B. Heimberger. (2015). Immunosuppressive mechanisms in glioblastoma: Fig. 1.. Neuro-Oncology. 17(suppl 7). vii9–vii14. 268 indexed citations

19.

Nduom, Edjah K., Jun Wei, Nasser K. Yaghi, et al.. (2015). PD-L1 expression and prognostic impact in glioblastoma. Neuro-Oncology. 18(2). 195–205. 457 indexed citations breakdown →

20.

Platt, Simon R., Edjah K. Nduom, Marc Kent, et al.. (2012). Canine Model of Convection-Enhanced Delivery of Cetuximab-Conjugated Iron-Oxide Nanoparticles Monitored With Magnetic Resonance Imaging. Neurosurgery. 59(Supplement 1). 107–113. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact